Current protocol in the United States does not include sonographic imaging for assessing proper placement of the Essure ® microinsert coils. An alternative to the current requirement of hysterosalpingography for imaging the metallic coils is described using 3D and 4D multiplanar imaging. Studies showing the advantages of using optimal sonographic techniques over other imaging modalities are shown to be less invasive, simpler, and with fewer risks. A review of 3D and 4D sonography reveals advantages in imaging the Essure microdevices.This article explores optimum techniques for localizing the Essure microdevices with 3D and 4D transvaginal sonography.
Background
Tubal ligation is the leading form of permanent sterilization used in the United States. 1 A more recent contraceptive procedure known as Essure ® (Conceptus, Inc, Mountain View, California) is a permanent birth control system being performed by an increasing number of gynecologists throughout the United States. It was approved by the European Union in 2001 and subsequently by the Food and Drug Administration (FDA) in 2002. 2 The Essure procedure is reported to be the "first non-incisional alternative to tubal ligation."
The procedure involves hysteroscopic placement of a microinsert coil into each fallopian tube to stimulate benign tissue growth and subsequent occlusion over a period of 3 to 6 months ( Figure 1 ). After 3 months, a hysterosalpinogram (HSG) is performed to confirm tubal occlusion. HSG is the gold standard for imaging and confirming occlusion of the fallopian tubes. 3 If problems arise before a 3-month period, an HSG can be performed earlier along with a plain film radiograph. If the HSG demonstrates dye in one of the tubes, it is assumed that occlusion has not taken place, and the patient continues with contraception for 3 more months. 1 Based on clinical trials of Essure testing of about 450 participants over 4 years, the placement of the microinserts was shown to be 99.80% effective, with occlusion occurring after 6 months. 4 Complications can include nonocclusion of one or both tubes, expulsion of the microinsert, perforation of the device, and migration of the coil outside of the tube.
Sonographic Evaluation
Currently, sonography is not a part of the approved reimbursement protocol for imaging the Essure microdevice in the United States. 2 However, European studies and surgical experience have shown sonography to be as effective as HSG in confirming sterilization at 12 weeks. 2 Although sonography alone without the saline infusion technique cannot confirm occlusion, it can identify the presence or absence of the coils in each cornua. Studies have evaluated other imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and sonography in the evaluation of the device. A study done by the Mayo Clinic found that all three modalities provided noninvasive and accurate identification of the Essure device. 5 One study as early as 2003 discussed the successful use of traditional 2D imaging for localization of the contraceptive coils. 6 Contrast infusion sonography, a minimally invasive technique introducing saline into the uterine cavity, has been explored and was shown to be effective in identifying the coils within each tube. It also demonstrated the absence of flow of the contrast saline agent to the tube, thus confirming occlusion. This method is deemed a less invasive course than the HSG, which introduces a radio-opaque dye into the tubes, using ionizing radiation to produce a radiographic image. 7 Additional studies have used only 2D transvaginal sonography without contrast infusion, which is less invasive yet still effective for localizing the Essure microdevices. Veersema et al. 8 evaluated 182 patients who underwent the Essure procedure. Transvaginal sonography was able to confirm proper placement of the devices in 150 of the 182 patients. The remainder of patients for whom placement could not be confirmed was due to the coil either being located too distally in the tube or because migration of the coil was suspected. For those patients whose devices were not successfully identified by transvaginal sonography, the Essure Confirmation Test, a low-pressure hysterosalpinogram was recommended. 
Protocol
Sonography can be used anytime after implantation. Many institutions perform 2D and 3D transvaginal imaging at the 3-month interval. 3, 6, [8] [9] [10] Booker et al. 10 described a transvaginal sonogram performed 1 month after the Essure sterilization procedure, which revealed a malpositioned microinsert that was expelled into the lower uterine cavity. Assuming the device would migrate earlier after implantation before tissue growth occurs, a screening with transvaginal imaging at the first office visit could be considered. The next screening would not be necessary for 3 months unless the patient experiences symptoms of pain or bleeding. Most patients require no further evaluation unless the sonography shows abnormal placement, at which time an HSG would be recommended for confirming malposition. 3, 9 
2D Appearance
A conventional 2D transvaginal sonogram in the transverse plane can demonstrate two nonshadowing bright echoes representing the coils in each cornu of the fundus. The desired coronal plane cannot be obtained routinely by this approach.
3D Appearance
In experienced hands, multiplanar transvaginal 3D sonography provides superior imaging of the Essure devices. It presents the uterus in the coronal plane where the microinserts can be identified in the cornua and their proximity to the endometrium ( Figure 2 ). The acquisition of the multiplanar images can be time-consuming when it involves postprocessing rendered manipulations (Figure 3 ). Simply stated, 4D mode is real-time 3D sonography. 11 Sonography has progressed allowing, realtime acquisition and display of 3D data sets to occur simultaneously. 4D is a quicker and simpler way of imaging the coronal plane of the uterus in real time. There is little need for postprocessing rendering. Thus, the whole screening technique is practically instantaneous. The sonographer can adjust the probe manually as well as manipulate the x-, y-, and z-planes in real time to obtain the optimal display of the coils in relation to the uterine cavity. It follows that 3D/4D is presently the best mode for efficient and quality imaging of the Essure microdevice. It is important to mention that when the 2D image is of poor quality due to uterine malposition, fibroids, body habitus, or excessive bowel, the 3D image will also be of poor quality.
Appearance of Improper Placement
There are two ways in which a coil can migrate from the desired position in the proximal tube. It is possible that soon after implantation, the tubes may spasm and expel the coil back into the endometrium (Figure 4 ). In this event, sonography can diagnose the malposition with accuracy and no further X-ray imaging needed. The second kind of malposition results from the coil migrating distally to some location outside of the tube ( Figure 5 ). This example may require a plain film X-ray to be ordered to determine the location of the other coil.
The use of plain film radiography can identify the coils in the pelvis but cannot define their relationship to the uterine canal and the tubes. If the coil is positioned distally in the tube, it may not be possible to visualize it sonographically. CT and MRI are reported to give similar imaging results as sonography, but none of these modalities can confirm occlusion in the tubes. 5 Veri fication of occlusion by either saline-infused hysterosonography or HSG is required in this type of malposition ( Figure 6 ).
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Discussion
Many studies have investigated 2D, 3D, and 4D sonography, confirming the accuracy of locating Essure microinserts. Sonography offers a very attractive alternative to HSG, radiology, CT, and MRI because it is noninvasive, is relatively low cost and nonpreparatory, does not use ionizing radiation, and can be accessed conveniently at your physician's office. HSG is uncomfortable for the patient and carries inherent risks (although rare) such as infection, vasovagal reaction, intravasation of radio-opaque dye, uterine perforation, and bleeding. 3 Weston and Bowditch 9 suggest that in-office sonography "should be the first-line investigation for confirmation of correct Essure placement." Optimal 3D over 2D transvaginal sonography increases the image quality by presenting a coronal plane of the uterus via multiplanar volume imaging. 4D accomplishes the same task more expediently in real time. This method is the most superior use of sonography available today. Defining the Essure coils and their rela tionship to the uterine cavity and cornua is an excellent example of sonography's latest imaging capabilities.
Conclusion
3D and 4D sonography continue to be underused, especially for gynecological applications. Studies have introduced the effectiveness of 3D and 4D imaging for locating Essure microdevices. These studies conclude that in most cases, alternative invasive methods that are uncomfortable and use ionizing radiation (e.g., HSG and plain film radiography) are not necessary except in the case of suspected malposition of the microinsert coils. In the discussion of 3D/4D sonography, it emphasizes the superior resolution and efficiency of transvaginal interrogation. The advantage of 4D over 3D is the real-time acquisition and manipulation of the image compared to 3D postprocessing. These techniques may be used to encourage and promote the use of this highly effective method for imaging Essure microdevices as well as other gynecological applications.
